Growing drug resistance has prompted continued interest in new chemical scaffolds with biological potential. Herein, we report a series of organyltellurium(IV) complexes, HMeF4AP(TeCl4), HMeF4AP(R1TeCl3), and HMeF4AP(R2TeCl2), based on an underexplored Schiff base ligand (HMeF4AP) derived from 5-hydroxymethylfurfural and 4-aminophenol, obtained in 68-84% yields. The ligand structure was confirmed by single-crystal X-ray diffraction, revealing a monoclinic system and bidentate (NO) coordination, while spectroscopic and thermal analyses supported an octahedral geometry around Te(IV). The complexes showed measurable in vitro biological activity; complex 4d exhibited the most potent antioxidant activity (IC50 ≈ 2.72 μM), whereas 4e and 4f displayed strong antimicrobial and antitubercular activity. DFT calculations analyzed electronic properties and structure-activity trends, molecular docking explored microbial target interactions, and ADMET studies confirmed favorable drug-likeness and pharmacokinetic behavior. Overall, these results highlight organyltellurium Schiff base systems as chemically stable bioactive scaffolds, warranting further investigation, and support their relevance for future medicinal chemistry studies.
Antil et al. (Wed,) studied this question.